Page 431 - Read Online
P. 431

J Cancer Metastasis Treat 2016;2 Suppl 1

           chemokine  (SDF-1), which  is involved  in adhesion   Jürgen Debus 6,15 , Claus Belka 7,16 ,  Steffi  Pigorsch 7,17 ,
           and migration  of  cancer stem  cells.  Additionally,   Stephanie E. Combs 7,17 , David Mönnich 8,18 , Daniel Zips 8,18 ,
           cathepsin X cleaves C-terminal ends of enolase and   Gustavo B. Baretton 1,21 , Frank Buchholz 1,22 , Michael
                                                                      1,9
           profilin, another two proteins that were suggested to   Baumann , Mechthild Krause 1,9
           alter cancer stem cells adhesion, migration and their   1 German Cancer Research Center (DKFZ), Heidelberg and German
           metastatic potential. Cathepsin X also cleaves beta-2   Cancer Consortium (DKTK) partner site: Dresden, Germany;
           chain in Mac-1 and LFA-1 integrin receptors and binds   2 German Cancer Research Center (DKFZ), Heidelberg and German
           to alpha-v-beta 5 integrin  receptor  via RGD motif in   Cancer Consortium (DKTK) partner site: Berlin, Germany;
                                                              German Cancer Research Center (DKFZ), Heidelberg and German
                                                              3
           the pro-region, affecting in this way the adhesion  of   Cancer Consortium (DKTK) partner site: Essen, Germany;
           endothelial  and tumor cells and presumably cancer   4 German Cancer Research Center (DKFZ), Heidelberg and German
           stem  cells. Cathepsin X  knock out  accelerates a   Cancer Consortium (DKTK) partner site: Frankfurt, Germany;
                                                              German Cancer Research Center (DKFZ), Heidelberg and German
                                                              5
           progress to senescence in vitro and in vivo via p16,   Cancer Consortium (DKTK) partner site: Freiburg, Germany;
           p21 and p53 signaling pathway.                     6 German Cancer Research Center (DKFZ), Heidelberg and German
                                                              Cancer Consortium (DKTK) partner site: Heidelberg, Germany;
                                                              7 German Cancer Research Center (DKFZ), Heidelberg and German
           The activity of cysteine  cathepsins  is regulated  by   Cancer Consortium (DKTK) partner site: Munich, Germany;
           endogenous  protein inhibitors cystatins. Of these,   8 German Cancer Research Center (DKFZ), Heidelberg and German
           cystatin F is the only  cystatin that is localized  in   Cancer Consortium (DKTK) partner site: Tübingen, Germany;
                                                              Universitätsklinikum Carl Gustav Carus der TU Dresden, Dresden, Germany;
                                                              9
           endosomal/lysosomal vesicles. In cytotoxic T cells and   10 OncoRay - National Center for Radiation Research in Oncology, Faculty of
           NK cells its main  role  is the control  of progranzyme   Medicine and University Hospital Carl Gustav Carus, Technische Universität
           convertase activity  of  cathepsins C  and H  and   Dresden, Dresden, Germany;
                                                               Department of Radiooncology and Radiotherapy, Charité University Hospital,
                                                              11
           consequently,  the granzyme dependent  cytotoxic   Berlin, Germany;
           function. It is known  that cytotoxic function of NK   12 Department of Radiotherapy, Medical Faculty, University of Duisburg-Essen,
           cells  is suppressed  after their  interaction  with tumor   Essen, Germany;
                                                               Department of Radiotherapy and Oncology, Goethe-University Frankfurt,
                                                              13
           cells or  cancer stem  cells, the  status  is termed split   Frankfurt, Germany;
           anergy. The mechanism includes cytokine cross-talk,   14 Department of Radiation Oncology, University of Freiburg, Freiburg, Germany;
                                                               Heidelberg Institute of Radiation Oncology (HIRO), National Center for
           however, target cells may also secrete inactive dimeric   15 Radiation Research in Oncology (NCRO), University of Heidelberg Medical
           cystatin F which after internalization to NK cells enters   School and German Cancer Research Center (DKFZ), Heidelberg, Germany;
           endosomal/lysosomal  vesicles and  after activation/  16 Department of Radiotherapy and Radiation Oncology, Ludwig-Maximilians-
           monomerisation  inhibits  cathepsins  C and H and   Universität, Munich, Germany;
                                                               Department of Radiation Oncology, Technische Universität München,
                                                              17
           down-regulates  cell cytotoxicity.  Anergized  NK cells   Munich, Germany;
           cause differentiation of cancer stem cells by secreted   18 Department of Radiation Oncology, Faculty of Medicine and University
           cytokines and as a result, differentiated tumors become   Hospital Tübingen, Eberhard Karls Universität Tübingen, Tübingen, Germany;
                                                              19
                                                               Department of Otorhinolaryngology, Faculty of Medicine and University Hospital
           resistant to NK cell-mediated cytotoxicity.        Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany;
                                                              20 Department of Oral and Maxillofacial Surgery, Faculty of Medicine and
           Our results show that some of cysteine cathepsins   University Hospital Carl Gustav Carus, Technische Universität Dresden,
                                                              Dresden, Germany;
           and  their  endogenous  inhibitors  have  specific  roles   21 Institute of Pathology, Faculty of Medicine and University Hospital Carl
           in cancer stem cell functions designating  them as   Gustav Carus, Technische Universität Dresden, Dresden, Germany;
                                                               University Cancer Center (UCC), Medical Systems Biology, University Hospital
           potential therapeutic targets for improving anticancer   22 Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
           therapy.
                                                              Aim: The outcome after curative treatment of locally
           Key words:                                         advanced head and neck squamous cell carcinoma
           Cathepsin, cystatin, anergy, SDF-1, profilin, enolase  (LA-HNSCC) remains unsatisfactory.  Except of
            A8                                                HPV-infection  status there is no further established
                                                              biomarker  for  treatment  stratification.  Currently,
           Hypoxia and expression levels of cancer            treatment decisions are mainly based on the tumor site
           stem cell markers are prognostic for loco-         and the TNM system regardless of the heterogeneous
           regional control after radiochemotherapy in        biology of HNSCC. For identification and validation of
           locally advanced head and neck squamous            biomarkers, the German Cancer Consortium Radiation
           cell carcinoma                                     Oncology Group (DKTK-ROG) initiated a multicenter
                                                              retrospective/prospective biomarker trial to explore their

           Fabian Lohaus , Annett Linge 1,10 , Steffen Löck , Volker   impact on locoregional control (LRC) after postoperative
                        1,9
                                                    10
           Gudziol ,  Alexander  Nowak , Cläre von Neubeck 1,10 ,   (PORT-C) and primary radiochemotherapy. Methods:
                                    20
                  19
           Inge  Tinhofer 2,11 ,  Volker Budach 2,11 , Ali  Sak 3,12 ,  Martin   In the multicenter retrospective part of the study,
           Stuschke 3,12 , Panagiotis Balermpas 4,13 , Claus Rödel 4,13 ,   355 patients with HNSCC of the oral cavity, oro- and
           Melanie Avlar 5,14 , Anca-Ligia Grosu 5,14 , Amir Abdollahi 6,15 ,   hypopharynx  were included.  All patients received
                           Journal of Cancer Metastasis and Treatment ¦ Volume 2 ¦ November 16, 2016      421
   426   427   428   429   430   431   432   433   434   435   436